Antag Therapeutics Alternatives & Competitors
12 companies similar to Antag Therapeutics — Redefining obesity treatment, empowering patients
Companies similar to Antag Therapeutics
NorthSea Therapeutics
Clinical-stage biopharmaceutical company focused on the development of structurally engine...
Amsterdam, The Netherland...
AAVantgarde
Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...
Marker Therapeutics, Inc.
Pioneering a Multi-Antigen Approach
Houston, United States
Glyscend Therapeutics
Advancing a new class of oral gut-targeted polymeric drugs for the treatment of T2D and Ob...
Lowell, United States
Rival Readout
Competing with Antag Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Legend Biotech
Multinational biopharmaceutical company focused on discovering and developing cutting-edge...
Somerset, United States
AptamiR Therapeutics
Pioneering the future of obesity treatment by converting stubborn fat into energy with pre...
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
Corteria Pharmaceuticals
Interceptive therapies for the treatment of heart failure subpopulations
Paris, France
NeuroSense Therapeutics
Creatively and diligently moving fast towards an effective treatment for people with ALS.
Cambridge, United States
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
HepaRegeniX GmbH
Unlocking liver regeneration - delivering recovery
Tubingen, Germany
Fate Therapeutics Inc.
Transforming the lives of patients with autoimmune diseases and cancer.
San Diego, United States
About Antag Therapeutics
Antag Therapeutics, founded in 2017, is a pioneering biotechnology company headquartered in Denmark. The company is focused on redefining obesity treatment and empowering patients through its innovative approach of GIP receptor antagonism. This methodology aims to deliver personal and flexible treatment options in the...
Development of GIP receptor antagonist therapies, Clinical research and trials, Monotherapy and combination therapy research
Individuals living with obesity, Patients with type 2 diabetes, Healthcare providers seeking novel obesity management solutions
Obesity Treatment, GIP Receptor Antagonism, Metabolic Health, Insulin Resistance, Peptide-based Therapeutics, Genetically-Validated Pathway, Metabolic Dysfunction, Fat Storage Reduction, Healthcare Innovation, Therapeutic Drug Development, Infusion Therapy, Dietary-Related Metabolic Diseases, Blood Flow Regulation, Lipid Uptake Management
B2B, B2C, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Antag Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Antag Therapeutics on 16 Mar 2026. The 12 companies listed here were last checked between 7 Jun 2025 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
